|
PT2585596T
(pt)
*
|
2010-06-23 |
2021-03-23 |
Curna Inc |
Tratamento de doenças relacionadas com a subunidade alfa de canais de sódio dependentes de voltagem (scna) por inibição da transcrição antissentido natural para scna
|
|
WO2012004743A1
(en)
|
2010-07-09 |
2012-01-12 |
Pfizer Limited |
Benzenesulfonamides useful as sodium channel inhibitors
|
|
EP2593432B1
(en)
|
2010-07-12 |
2014-10-22 |
Pfizer Limited |
N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
|
|
JP2013532186A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
WO2012007883A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
|
|
EP2593431B1
(en)
|
2010-07-12 |
2014-11-19 |
Pfizer Limited |
N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels
|
|
JP2013532185A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
EP2655330B1
(en)
*
|
2010-12-22 |
2016-02-10 |
Purdue Pharma LP |
Substituted pyridines as sodium channel blockers
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
KR20150087400A
(ko)
|
2012-11-20 |
2015-07-29 |
버텍스 파마슈티칼스 인코포레이티드 |
인돌아민 2,3-디옥시게나제의 억제제로서 유용한 화합물
|
|
AR095192A1
(es)
|
2013-01-31 |
2015-09-30 |
Vertex Pharma |
Quinolina y quinazolinamidas como modulares de canales de sodio
|
|
AR094667A1
(es)
|
2013-01-31 |
2015-08-19 |
Vertex Pharma |
Piridonamidas como moduladores de canales de sodio
|
|
US9108903B2
(en)
*
|
2013-01-31 |
2015-08-18 |
Vertex Pharmaceuticals Incorporated |
Amides as modulators of sodium channels
|
|
CA2918365C
(en)
*
|
2013-07-19 |
2021-09-07 |
Vertex Pharmaceuticals Incorporated |
Sulfonamides as modulators of sodium channels
|
|
UA121379C2
(uk)
*
|
2013-12-13 |
2020-05-25 |
Вертекс Фармасьютикалз Інкорпорейтед |
Проліки піридонамідів, застосовувані як модулятори натрієвих каналів
|
|
US9594075B2
(en)
|
2014-04-22 |
2017-03-14 |
Q-State Biosciences, Inc. |
Diagnostic methods for neural disorders
|
|
US10048275B2
(en)
|
2015-03-13 |
2018-08-14 |
Q-State Biosciences, Inc. |
Cardiotoxicity screening methods
|
|
EP3298448B1
(en)
|
2015-05-21 |
2024-09-04 |
President and Fellows of Harvard College |
Optogenetics microscope
|
|
MX386261B
(es)
|
2015-10-07 |
2025-03-18 |
Univ Arizona |
Inhibidores de sumoilacion de crmp2 y usos de los mismos
|
|
WO2018009618A1
(en)
*
|
2016-07-07 |
2018-01-11 |
Dow Agrosciences Llc |
Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamides
|
|
JP7104070B2
(ja)
|
2017-05-16 |
2022-07-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ナトリウムチャネルの調節因子としての重水素化ピリドンアミドおよびそのプロドラッグ
|
|
ES3008911T3
(en)
|
2017-07-11 |
2025-03-25 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
US20190343817A1
(en)
|
2018-02-12 |
2019-11-14 |
Vertex Pharmaceuticals Incorporated |
Method of treating pain
|
|
CN112689629B
(zh)
|
2018-07-09 |
2024-04-23 |
利伯研究所公司 |
用于抑制Nav1.8的哒嗪化合物
|
|
CA3105657A1
(en)
*
|
2018-07-09 |
2020-01-16 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting nav1.8
|
|
CN110885328B
(zh)
*
|
2018-09-10 |
2022-08-12 |
成都康弘药业集团股份有限公司 |
作为钠通道阻滞剂的磺酰胺类化合物及其用途
|
|
EP3873468A4
(en)
*
|
2018-11-02 |
2022-10-26 |
Merck Sharp & Dohme LLC |
2-AMINO-N-PHENYL-NICOTINAMIDES AS NAV1.8 INHIBITORS
|
|
JOP20210097A1
(ar)
|
2018-11-02 |
2023-01-30 |
Merck Sharp & Dohme |
مركبات 2-أمينو-n-أريل غير متجانس-نيكوتيناميد كمثبطات nav1.8
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
*
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
CN112390745B
(zh)
*
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
|
JP2022548104A
(ja)
*
|
2019-09-12 |
2022-11-16 |
オリオン コーポレーション |
ピリジン窒素酸化物及びその製造方法と使用
|
|
SI4069691T1
(sl)
|
2019-12-06 |
2025-02-28 |
Vertex Pharmaceuticals Incorporated |
Substituirani tetrahidrofurani kot modulatorji natrijevih kanalčkov
|
|
CN113045487B
(zh)
*
|
2019-12-27 |
2025-01-17 |
明慧医药（上海）有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
MX2022015581A
(es)
|
2020-06-17 |
2023-01-24 |
Merck Sharp & Dohme Llc |
2-oxoimidazolidin-4-carboxamidas como inhibidores de nav1.8.
|
|
BR112023023239A2
(pt)
|
2021-05-07 |
2024-01-23 |
Merck Sharp & Dohme Llc |
Carboxamidas de cicloalquil 3-oxopiperazina e carboxamidas de cicloheteroalquil 3-oxopiperazina como inibidores de nav1.8
|
|
EP4347031B1
(en)
|
2021-06-04 |
2025-10-29 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|
|
US11999699B2
(en)
|
2021-06-15 |
2024-06-04 |
Grünenthal GmbH |
Substituted pyrazole amides
|
|
CR20240513A
(es)
|
2022-04-22 |
2025-04-30 |
Vertex Pharma |
Compuestos de heteroarilo para el tratamiento del dolor
|
|
WO2024032774A1
(zh)
*
|
2022-08-12 |
2024-02-15 |
广州费米子科技有限责任公司 |
用作电压-门控钠通道抑制剂的化合物
|
|
EP4385984A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Pyridine-n-oxides as inhibitors of nav1.8
|
|
AR131345A1
(es)
|
2022-12-14 |
2025-03-12 |
Gruenenthal Gmbh |
SULFOXIMINAS COMO INHIBIDORES DE NaV1.8
|
|
EP4385980A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Indazoles as inhibitors of nav1.8
|
|
EP4385979A1
(en)
|
2022-12-14 |
2024-06-19 |
Grünenthal GmbH |
Multicyclic inhibitors of nav1.8
|
|
CN118324743A
(zh)
*
|
2023-04-19 |
2024-07-12 |
中国科学院上海药物研究所 |
Nav1.8抑制剂及其制备方法和用途
|